Investigation of bacterial inactivation in apheresis platelets with 24 or 30 hours between inoculation and inactivation.

Wagner, S J; Benjamin, R J; Hapip, C A; Kaelber, N S; Turgeon, A M; Skripchenko, A; Stassinopoulos, A

Wagner, S J; Benjamin, R J; Hapip, C A; Kaelber, N S; Turgeon, A M; Skripchenko, A; Stassinopoulos, A.

Affiliation

Wagner SJ; Transfusion Innovation Department, American Red Cross Holland Laboratory, Rockville, MD, USA. stephen.wagner@redcross.org.
Benjamin RJ; Cerus Corporation, Concord, CA, USA.
Hapip CA; Transfusion Innovation Department, American Red Cross Holland Laboratory, Rockville, MD, USA.
Kaelber NS; Transfusion Innovation Department, American Red Cross Holland Laboratory, Rockville, MD, USA.
Turgeon AM; Transfusion Innovation Department, American Red Cross Holland Laboratory, Rockville, MD, USA.
Skripchenko A; Transfusion Innovation Department, American Red Cross Holland Laboratory, Rockville, MD, USA.
Stassinopoulos A; Cerus Corporation, Concord, CA, USA.

Vox Sang ; 111(3): 226-234, 2016 Oct.

Article de En | MEDLINE | ID: mdl-27185478

Sujet(s)
Mots clés

bacteria; inactivation; platelet

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Furocoumarines / Bactéries / Plaquettes / Photosensibilisants Limites: Humans Langue: En Journal: Vox Sang Année: 2016 Type de document: Article Pays d'affiliation: États-Unis d'Amérique

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google